A summary of second systemic pulmonary shunt for congenital heart disease with pulmonary hypoxemia

Yang XY, Jing XY, Chen Z, Li L, Fan XM, Su JW.Version 2. J Cardiothorac Surg. 2020 May 14;15(1):97. doi: 10.1186/s13019-020-01132-z.PMID: 32410655 Free PMC article.



Background: There has been an increasing number of children with congenital heart disease that undergo primary or second systemic-pulmonary shunt, while there are few reports on the second systemic-pulmonary shunt. Therefore, this study summarizes the experience of second systemic-pulmonary shunt for congenital heart disease in our hospital.

Methods and results: Sixty-five children with congenital heart disease who underwent systemic-pulmonary shunt for the second time in our hospital were analyzed. At the early stage after the operation, cyanosis improved and SpO2 significantly increased. One patient died in hospital (1.54%) and the causes of death were aggravated atrioventricular regurgitation, low cardiac output syndrome, and liver failure. Early complications occurred in 18 patients (27.7%). All the children were rechecked in our hospital every 3-6 months and the McGoon index significantly increased.

Conclusion: Systemic-pulmonary artery shunt can promote pulmonary vascular development, improve cyanosis symptoms, and increase the chance of radical treatment in children with pulmonary vascular dysplasia.




Dive straight into the feedback!
Login below and you can start commenting using your own user instantly